Using estimated yearly progression rates to compare radiographic data across recent randomised controlled trials in rheumatoid arthritis
- 1 November 2002
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 61 (suppl 2) , ii64-ii66
- https://doi.org/10.1136/ard.61.suppl_2.ii64
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazineAnnals of the Rheumatic Diseases, 2001
- Recent rheumatoid arthritis clinical trials using radiographic endpoints--updated research agenda.2001
- Radiography of rheumatoid arthritis in the time of increasing drug effectivenessCurrent Rheumatology Reports, 2001
- Infliximab and Methotrexate in the Treatment of Rheumatoid ArthritisNew England Journal of Medicine, 2000
- A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid ArthritisNew England Journal of Medicine, 2000
- A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritisRheumatology, 2000
- A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: Radiologic progression and correlation of genant and larsen scoresArthritis & Rheumatism, 2000
- Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: Results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritisArthritis & Rheumatism, 2000
- Treatment of Active Rheumatoid Arthritis With Leflunomide Compared With Placebo and MethotrexateArchives of internal medicine (1960), 1999
- How to read radiographs according to the Sharp/van der Heijde method.1999